Company Filing History:
4 out of 9 
4 out of 815 
4 out of 134 
Years Active: 2017-2022
Title: **Innovative Contributions of Inventor Jenny Low in Dengue Treatment**
Introduction
Jenny Low is a notable inventor based in Singapore, recognized for her significant contributions to healthcare innovations. With a total of four patents to her name, her research focuses primarily on developing methods for the treatment and prevention of dengue virus infections.
Latest Patents
Jenny Low's recent patents include two pivotal innovations aimed at tackling dengue infections. The first patent introduces dosing regimens of celgosivir for treating dengue, detailing methods to administer a pharmaceutical composition to human subjects within 72 hours of fever onset. This regimen is designed to improve conditions caused by primary and secondary DENV 1-4 viral infections.
The second patent outlines preventive measures against dengue, proposing a dosing schedule for administering celgosivir to asymptomatic individuals, thus aiming to avert disease resulting from dengue virus infections.
Career Highlights
Throughout her career, Jenny Low has made significant strides in the pharmaceutical field. She has worked for notable organizations, including 60 Degrees Pharmaceuticals, LLC and the National University of Singapore. Her expertise in innovative treatments has placed her at the forefront of research in viral infections.
Collaborations
Jenny has collaborated with distinguished professionals in her field, including Geoffrey Stuart Dow and Subhash G Vasudevan. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative concepts.
Conclusion
In summary, Jenny Low's impactful patents and collaborative efforts are instrumental in advancing treatment methodologies for dengue infections. Her contributions highlight the importance of innovative solutions to global health challenges and reinforce her standing as a prominent inventor in the field of medical research.